OncoMed Pharmaceuticals, Inc. 5,500,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • August 23rd, 2016 • OncoMed Pharmaceuticals Inc • Pharmaceutical preparations • New York
OncoMed Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 5,500,000 shares (the “Firm Shares”) and, at the election of the Underwriters, up to 825,000 additional shares (the “Optional Shares”) of common stock, par value $0.001 per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
